237 related articles for article (PubMed ID: 17392504)
1. The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway.
Chen Z; Naveiras O; Balduini A; Mammoto A; Conti MA; Adelstein RS; Ingber D; Daley GQ; Shivdasani RA
Blood; 2007 Jul; 110(1):171-9. PubMed ID: 17392504
[TBL] [Abstract][Full Text] [Related]
2. Proplatelet formation is regulated by the Rho/ROCK pathway.
Chang Y; Auradé F; Larbret F; Zhang Y; Le Couedic JP; Momeux L; Larghero J; Bertoglio J; Louache F; Cramer E; Vainchenker W; Debili N
Blood; 2007 May; 109(10):4229-36. PubMed ID: 17244674
[TBL] [Abstract][Full Text] [Related]
3. Regulation of platelet biogenesis: insights from the May-Hegglin anomaly and other MYH9-related disorders.
Chen Z; Shivdasani RA
J Thromb Haemost; 2009 Jul; 7 Suppl 1():272-6. PubMed ID: 19630815
[TBL] [Abstract][Full Text] [Related]
4. The abnormal proplatelet formation in MYH9-related macrothrombocytopenia results from an increased actomyosin contractility and is rescued by myosin IIA inhibition.
Chen Y; Boukour S; Milloud R; Favier R; Saposnik B; Schlegel N; Nurden A; Raslova H; Vainchenker W; Balland M; Nurden P; Debili N
J Thromb Haemost; 2013 Dec; 11(12):2163-75. PubMed ID: 24165359
[TBL] [Abstract][Full Text] [Related]
5. Abnormal megakaryocyte morphology and proplatelet formation in mice with megakaryocyte-restricted MYH9 inactivation.
Eckly A; Strassel C; Freund M; Cazenave JP; Lanza F; Gachet C; Léon C
Blood; 2009 Apr; 113(14):3182-9. PubMed ID: 18984861
[TBL] [Abstract][Full Text] [Related]
6. Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease.
Pal K; Nowak R; Billington N; Liu R; Ghosh A; Sellers JR; Fowler VM
Blood; 2020 May; 135(21):1887-1898. PubMed ID: 32315395
[TBL] [Abstract][Full Text] [Related]
7. Proplatelet formation deficit and megakaryocyte death contribute to thrombocytopenia in Myh9 knockout mice.
Eckly A; Rinckel JY; Laeuffer P; Cazenave JP; Lanza F; Gachet C; Léon C
J Thromb Haemost; 2010 Oct; 8(10):2243-51. PubMed ID: 20695978
[TBL] [Abstract][Full Text] [Related]
8. Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
Egot M; Lasne D; Poirault-Chassac S; Mirault T; Pidard D; Dreano E; Elie C; Gandrille S; Marchelli A; Baruch D; Rendu J; Fauré J; Flaujac C; Gratacap MP; Sié P; Gaussem P; Salomon R; Baujat G; Bachelot-Loza C
Br J Haematol; 2021 Mar; 192(5):909-921. PubMed ID: 33528045
[TBL] [Abstract][Full Text] [Related]
9. Calyculin A retraction of mature megakaryocytes proplatelets from embryonic stem cells.
Tamaru S; Kitajima K; Nakano T; Eto K; Yazaki A; Kobayashi T; Matsumoto T; Wada H; Katayama N; Nishikawa M
Biochem Biophys Res Commun; 2008 Feb; 366(3):763-8. PubMed ID: 18083116
[TBL] [Abstract][Full Text] [Related]
10. Myosin IIA is critical for organelle distribution and F-actin organization in megakaryocytes and platelets.
Pertuy F; Eckly A; Weber J; Proamer F; Rinckel JY; Lanza F; Gachet C; Léon C
Blood; 2014 Feb; 123(8):1261-9. PubMed ID: 24243973
[TBL] [Abstract][Full Text] [Related]
11. Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes.
Shin JW; Swift J; Spinler KR; Discher DE
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11458-63. PubMed ID: 21709232
[TBL] [Abstract][Full Text] [Related]
12. The critical role of myosin IIA in platelet internal contraction.
Johnson GJ; Leis LA; Krumwiede MD; White JG
J Thromb Haemost; 2007 Jul; 5(7):1516-29. PubMed ID: 17488351
[TBL] [Abstract][Full Text] [Related]
13. Importance of environmental stiffness for megakaryocyte differentiation and proplatelet formation.
Aguilar A; Pertuy F; Eckly A; Strassel C; Collin D; Gachet C; Lanza F; Léon C
Blood; 2016 Oct; 128(16):2022-2032. PubMed ID: 27503502
[TBL] [Abstract][Full Text] [Related]
14. Convulxin induces platelet shape change through myosin light chain kinase and Rho kinase.
Riondino S; Gazzaniga PP; Pulcinelli FM
Eur J Biochem; 2002 Dec; 269(23):5878-84. PubMed ID: 12444976
[TBL] [Abstract][Full Text] [Related]
15. Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes.
Balduini A; Pallotta I; Malara A; Lova P; Pecci A; Viarengo G; Balduini CL; Torti M
J Thromb Haemost; 2008 Nov; 6(11):1900-7. PubMed ID: 18752571
[TBL] [Abstract][Full Text] [Related]
16. Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells.
Pecci A; Bozzi V; Panza E; Barozzi S; Gruppi C; Seri M; Balduini CL
Thromb Haemost; 2011 Oct; 106(4):693-704. PubMed ID: 21833445
[TBL] [Abstract][Full Text] [Related]
17. Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation.
Pecci A; Malara A; Badalucco S; Bozzi V; Torti M; Balduini CL; Balduini A
Thromb Haemost; 2009 Jul; 102(1):90-6. PubMed ID: 19572073
[TBL] [Abstract][Full Text] [Related]
18. Myosin-II repression favors pre/proplatelets but shear activation generates platelets and fails in macrothrombocytopenia.
Spinler KR; Shin JW; Lambert MP; Discher DE
Blood; 2015 Jan; 125(3):525-33. PubMed ID: 25395423
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric distribution of myosin IIB in migrating endothelial cells is regulated by a rho-dependent kinase and contributes to tail retraction.
Kolega J
Mol Biol Cell; 2003 Dec; 14(12):4745-57. PubMed ID: 12960430
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes.
Murai K; Kowata S; Shimoyama T; Yashima-Abo A; Fujishima Y; Ito S; Ishida Y
Eur J Haematol; 2014 Oct; 93(4):290-6. PubMed ID: 24750292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
